Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05154474
What this trial is testing

Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy

Who this might be right for
Metastatic CancerCancer, BreastCancer Colon+12 more
Weprom 150
Testing effectiveness (Phase 2)UnknownNCT00408551
What this trial is testing

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Goshen Health System 20
Not applicableStudy completedNCT06982053
What this trial is testing

[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy

Who this might be right for
Colorectal Cancer Control and PreventionColorectal Cancer RecurrentColorectal Cancer Metastatic+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 21
Testing effectiveness (Phase 2)Study completedNCT00100841
What this trial is testing

Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

Who this might be right for
Adenocarcinoma of the RectumMucinous Adenocarcinoma of the ColonRecurrent Colon Cancer+4 more
National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT01205022
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
City of Hope Medical Center 3
Post-approval studies (Phase 4)Study completedNCT06843954
What this trial is testing

Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer

Who this might be right for
Colo-rectal Cancer
Mohammed Mahmood Mohammed 157
Not applicableUnknownNCT05830890
What this trial is testing

Sentinel Lymph Node Biopsy in Rectal Cancer

Who this might be right for
Rectal Cancer Stage IIIRectal Cancer Stage IV
National Cancer Center, China 87
Not applicableStudy completedNCT03154190
What this trial is testing

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Who this might be right for
Acute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more
Stanford University 128
Testing effectiveness (Phase 2)Study completedNCT00002997
What this trial is testing

Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT00003354
What this trial is testing

Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council 1,200
Testing effectiveness (Phase 2)Study completedNCT00268333
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 39
Testing effectiveness (Phase 2)Study completedNCT00041652
What this trial is testing

Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer

Who this might be right for
Colorectal CancerColon CancerRectal Cancer+4 more
Gilead Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00041340
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)WithdrawnNCT00571740
What this trial is testing

Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology
Early research (Phase 1)UnknownNCT03775525
What this trial is testing

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Advanced CancerGastric CancerBreast Cancer+14 more
Genzada Pharmaceuticals USA, Inc. 127
Testing effectiveness (Phase 2)Study completedNCT00625651
What this trial is testing

Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerColon CancerColorectal Cancer+1 more
Amgen 202
Early research (Phase 1)Study completedNCT00004095
What this trial is testing

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+3 more
Northwestern University 38
Testing effectiveness (Phase 2)Study completedNCT00004895
What this trial is testing

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+7 more
Northwestern University
Early research (Phase 1)Temporarily pausedNCT05400122
What this trial is testing

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Who this might be right for
Colorectal CancerHematologic MalignancyRectum Cancer+15 more
David Wald 12
Testing effectiveness (Phase 2)Ended earlyNCT00845039
What this trial is testing

Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab

Who this might be right for
Colon CancerRectal Cancer
Eli Lilly and Company 4
Next Page